Back to search

Finland· FI-REL-REL1166

Palacos Cum Gentamicin

A other non-therapeutic auxiliary products product containing methyl methacrylate + methyl methacrylate-methyl acrylate copolymer + gentamicin sulfate, registered in Finland by Schering Corporation. The same ATC class is registered in 2 of our 19 countries.

ATC V07AY

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedPalacos Cum GentamicinATCV07AYREGISTER NO.FI-REL-REL1166PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Methyl methacrylate + methyl methacrylate-methyl acrylate copolymer + gentamicin sulfate is registered in 2 of 19 countries.

Countries holding a registration under ATC V07AY (other non-therapeutic auxiliary products), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose

Methyl methacrylate + methyl methacrylate-methyl acrylate copolymer + gentamicin sulfate · ATC V07AY

2 / 19 countries

  • Finlandprice
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Methyl methacrylate + Methyl methacrylate-methyl acrylate copolymer + Gentamicin sulfate
Manufacturer
Schering Corporation
Country
Finland (FI)
ATC code
V07AY
ATC class
Other non-therapeutic auxiliary products
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8e4011b-3fac-4a2b-8689-c7fd0887c61b
GET /v1/drugs/d8e4011b-3fac-4a2b-8689-c7fd0887c61b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "luusementti",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Muut ei-terapeuttiset apuvalmisteet",
  "ma_number": "7457",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1166",
  "authorised_at": "1977-08-17"
}

See everything about methyl methacrylate + methyl methacrylate-methyl acrylate copolymer + gentamicin sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.